Monetary Management Group Inc Ligand Pharmaceuticals Inc Transaction History

Monetary Management Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $527,953 - $1.14 Million	-5,305 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $13,434 - $19,008	-150 Reduced 2.75%	5,305 $506,000
Q2 2020 Aug 13, 2020	BUY	$68.28 - $123.65 $330,133 - $597,847	4,835 Added 779.84%	5,455 $610,000
Q4 2019 Feb 13, 2020	BUY	$96.94 - $113.59 $60,102 - $70,425	620 New	620 $65,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

Stay updated on Monetary Management Group Inc with notifications on news.